Cian Healthcare Ltd
Incorporated in 2003, Cian Healthcare Ltd is engaged in manufacturing and marketing of pharmaceutical products.[1]
- Market Cap ₹ 14.3 Cr.
- Current Price ₹ 5.73
- High / Low ₹ 7.66 / 2.97
- Stock P/E
- Book Value ₹ 15.2
- Dividend Yield 0.00 %
- ROCE -5.70 %
- ROE -14.3 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.38 times its book value
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -11.6% over past five years.
- Promoter holding is low: 27.1%
- Company has a low return on equity of -3.43% over last 3 years.
- Company might be capitalizing the interest cost
- Promoters have pledged or encumbered 34.5% of their holding.
- Company has high debtors of 184 days.
- Promoter holding has decreased over last 3 years: -39.2%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22.60 | 30.93 | 46.68 | 51.78 | 65.90 | 62.44 | 57.05 | 72.38 | 64.10 | 67.56 | 58.75 | 30.88 | 23.66 | |
| 19.05 | 26.02 | 39.08 | 41.68 | 52.93 | 54.54 | 49.34 | 62.86 | 59.06 | 58.49 | 51.19 | 33.79 | 30.36 | |
| Operating Profit | 3.55 | 4.91 | 7.60 | 10.10 | 12.97 | 7.90 | 7.71 | 9.52 | 5.04 | 9.07 | 7.56 | -2.91 | -6.70 |
| OPM % | 15.71% | 15.87% | 16.28% | 19.51% | 19.68% | 12.65% | 13.51% | 13.15% | 7.86% | 13.43% | 12.87% | -9.42% | -28.32% |
| 0.14 | 0.21 | 0.47 | 0.07 | 0.18 | 0.95 | 0.72 | 0.00 | 0.40 | 0.56 | 1.06 | -12.00 | 0.62 | |
| Interest | 1.25 | 1.48 | 3.98 | 5.14 | 5.94 | 5.52 | 5.90 | 6.40 | 5.25 | 4.79 | 4.93 | 2.16 | 0.06 |
| Depreciation | 0.16 | 0.88 | 1.93 | 1.95 | 1.95 | 2.39 | 2.45 | 2.45 | 2.57 | 3.64 | 3.68 | 2.61 | 2.12 |
| Profit before tax | 2.28 | 2.76 | 2.16 | 3.08 | 5.26 | 0.94 | 0.08 | 0.67 | -2.38 | 1.20 | 0.01 | -19.68 | -8.26 |
| Tax % | 32.46% | 32.25% | 28.70% | 24.68% | 23.95% | 30.85% | 187.50% | 50.75% | -4.20% | 10.00% | -3,800.00% | -0.10% | |
| 1.54 | 1.86 | 1.55 | 2.31 | 4.00 | 0.66 | -0.07 | 0.33 | -2.28 | 1.08 | 0.39 | -19.66 | -8.33 | |
| EPS in Rs | 154.00 | 186.00 | 110.71 | 165.00 | 285.71 | 0.38 | -0.03 | 0.14 | -0.91 | 0.43 | 0.16 | -7.87 | -3.34 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -12% |
| 3 Years: | -22% |
| TTM: | -49% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -299% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -17% |
| 3 Years: | -31% |
| 1 Year: | 19% |
| Return on Equity | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -3% |
| 3 Years: | -3% |
| Last Year: | -14% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.00 | 1.00 | 1.40 | 1.40 | 1.40 | 17.14 | 23.36 | 23.36 | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 |
| Reserves | 5.37 | 7.23 | 9.58 | 11.89 | 16.34 | 4.56 | 36.19 | 36.51 | 35.35 | 36.43 | 36.82 | 17.16 | 12.97 |
| 15.96 | 32.00 | 31.06 | 39.68 | 50.41 | 48.66 | 51.22 | 49.30 | 43.08 | 42.72 | 41.01 | 39.99 | 39.99 | |
| 3.79 | 6.09 | 14.78 | 8.31 | 8.42 | 21.66 | 23.92 | 25.47 | 36.36 | 36.48 | 40.06 | 60.53 | 57.34 | |
| Total Liabilities | 26.12 | 46.32 | 56.82 | 61.28 | 76.57 | 92.02 | 134.69 | 134.64 | 139.79 | 140.63 | 142.89 | 142.68 | 135.30 |
| 2.50 | 19.40 | 18.14 | 21.48 | 20.00 | 23.48 | 20.78 | 18.73 | 32.82 | 29.42 | 25.88 | 23.32 | 22.29 | |
| CWIP | 9.71 | 4.78 | 5.38 | 3.69 | 6.56 | 6.37 | 24.80 | 25.71 | 13.00 | 13.89 | 14.70 | 15.07 | 15.07 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.09 | 7.09 | 7.09 | 7.09 | 7.09 | 7.09 | 7.09 |
| 13.91 | 22.14 | 33.30 | 36.11 | 50.01 | 62.17 | 82.02 | 83.11 | 86.88 | 90.23 | 95.22 | 97.20 | 90.85 | |
| Total Assets | 26.12 | 46.32 | 56.82 | 61.28 | 76.57 | 92.02 | 134.69 | 134.64 | 139.79 | 140.63 | 142.89 | 142.68 | 135.30 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00 | 9.89 | 6.03 | 7.74 | 12.80 | -9.24 | 5.46 | 5.51 | 2.15 | 6.94 | 20.66 | |
| 0.00 | 0.00 | -5.08 | -4.02 | -2.69 | -8.32 | -25.16 | -1.20 | -3.85 | -1.08 | -0.93 | -0.27 | |
| 0.00 | 0.00 | -4.74 | -1.51 | -5.53 | -2.74 | 35.09 | -5.07 | -2.65 | -1.17 | -6.41 | -3.46 | |
| Net Cash Flow | 0.00 | 0.00 | 0.07 | 0.50 | -0.48 | 1.74 | 0.69 | -0.81 | -0.99 | -0.10 | -0.40 | 16.93 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 121.29 | 115.88 | 95.47 | 96.85 | 141.62 | 129.89 | 127.64 | 93.49 | 103.98 | 127.18 | 113.69 | 183.68 |
| Inventory Days | 169.27 | 158.62 | 137.27 | 127.72 | 160.45 | 144.03 | 267.18 | 260.38 | 324.72 | 310.27 | 404.15 | 460.88 |
| Days Payable | 60.32 | 70.56 | 122.04 | 20.77 | 53.01 | 143.67 | 216.64 | 179.36 | 274.80 | 210.62 | 269.65 | 609.29 |
| Cash Conversion Cycle | 230.24 | 203.94 | 110.70 | 203.81 | 249.07 | 130.25 | 178.17 | 174.52 | 153.90 | 226.83 | 248.20 | 35.27 |
| Working Capital Days | 55.88 | 51.57 | 16.65 | 40.32 | 56.27 | 44.19 | 5.31 | 12.15 | 60.93 | 49.27 | 48.89 | -570.67 |
| ROCE % | 20.16% | 13.55% | 14.93% | 17.30% | 18.49% | 9.39% | 6.68% | 6.61% | 2.77% | 5.74% | 4.77% | -5.70% |
Documents
Announcements
-
Clarification Regarding Extension Of Annual General Meeting ('AGM') Of Cian Healthcare Limited ('Company').
29 Nov - MCA portal error blocked Form GNL-1; ROC approved GNL-2 deemed extension; AGM by Dec 31, 2025.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
27 Nov - Newspaper Advertisement regarding Corrigendum to the Notice of the 22nd Annual General Meeting ("AGM") of the Company.
-
Corrigendum To The Notice Of 22Nd Annual General Meeting ("AGM") Of The Company Scheduled To Be Held On Wednesday, December 17, 2025 At 10:00 A.M. Through Video Conferencing/Other Audio-Visual Means.
25 Nov - Corrigendum adding ratification of Rs45,000 cost auditor fee; AGM Dec 17, 2025; company under CIRP.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
25 Nov - Newspaper Publication of the Notice of 22nd Annual General Meeting ("AGM") of the Company.
-
Reg. 34 (1) Annual Report.
24 Nov - AGM on Dec 17, 2025; NCLT reserved approval of resolution plan for Pradeep Kumar Jain.
Business Overview:[1][2]
CHI is a fully integrated pharmaceutical company dealing in gynecology, hematinic, cardio-diabetic, orthopedic, pediatric, derma-cosmetic, antibiotic, CNS, vitamins & nutrient products.